Weill Cornell Bone Marrow Transplant Program

Treatment of Para-influenza Virus in Transplant Patients

Leave a comment

Para-influenza virus is common in the community and can cause severe and sometimes life-threatening pneumonias.  Patel et al, tested the novel drug DAS181 in transplant patients with such infections an report encouraging outcomes.

Salvatore et al, DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center, Biology of Blood and Marrow Transplantation, February 2016.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s